Leerink Partners analyst Daina Graybosch maintained a Buy rating on Nkarta (NKTX – Research Report) yesterday and set a price target of $7.00.

Leerink Partners analyst Daina Graybosch maintained a Buy rating on Century Therapeutics (IPSC – Research Report) yesterday and set a price ...

Cindy Perettie; Executive Vice President of Kite; Gilead Sciences Inc. Geoffrey Meacham; Analyst; Citi. Terence Flynn; Analyst; Morgan Stanley. Timothy Anderson; Analyst; BofA Glo ...

Good afternoon, everyone, and welcome to Gilead's fourth quarter and full year 2024 earnings conference call. My name is Rebecca, and I'll be today's host. In a moment, we'll begin our prepared ...

VIENTIANE: The Indochina Bank has officially launched its latest product, the ‘Daina Pay’, to facilitate transactions including the payment of urgent bills. The bank’s managing director ...

Leerink Partnrs analyst D. Graybosch anticipates that the company will post earnings per share of ($1.74) for the year. The consensus estimate for Nkarta’s current full-year earnings is ($1.68 ...

Leerink Partnrs analyst D. Graybosch anticipates that the biopharmaceutical company will post earnings per share of ($0.46) for the quarter. The consensus estimate for Fate Therapeutics’ current ...

Academy Award-nominated actor John Lithgow is reportedly closing in on a deal to play Headmaster Albus Dumbledore in the upcoming HBO Harry Potter series. Celebrity AI video protests Kanye West ...